FEMASYS INC 8-K

What Happened Femasys Inc. announced via a Form 8-K (filed May 13, 2026) that it posted an updated slide presentation on its website. The presentation is furnished under Regulation FD (Item 7.01) and is attached to the filing as Exhibit 99.1; company representatives will use the slides in meetings with investors, analysts and other parties.

Key Details

• Filing date: May 13, 2026; SEC accession no. 0001140361-26-021081.
• Item reported: 7.01 (Regulation FD disclosure); Exhibit 99.1 is the updated slide presentation/press release.
• The presentation was furnished (not filed) with the 8-K and will be used in investor/analyst meetings.
• Item 9.01 lists the exhibit (99.1); no new financial statements or other material changes were reported in this 8-K.

Why It Matters This 8-K notifies investors that Femasys has made its latest investor materials publicly available and will use them in outreach. The filing itself does not present new financial results or executive changes; investors seeking substantive updates (strategy, product, clinical, or financial detail) should review Exhibit 99.1 on the SEC EDGAR site or the company’s investor relations page.